首页 > 最新文献

Current Urology最新文献

英文 中文
Advancements in the management of overactive bladder in women using nano-botulinum toxin type A: A narrative review. 纳米A型肉毒杆菌毒素治疗女性膀胱过动症的进展:综述。
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-21 DOI: 10.1097/CU9.0000000000000272
Yongheng Zhou, Qinggang Liu, Huiling Cong, Limin Liao

Intravesical injections of botulinum toxin type A (BTX-A) are effective for treating refractory overactive bladder (OAB) in women. However, the adverse effects linked to the injections, such as hematuria, pain, and infection, and need for repeated injections can lower patient compliance and make the treatment inconvenient. Hence, urologists are actively pursuing less invasive and more convenient methods for the intravesical delivery of BTX-A. Advances in nanotechnology have facilitated noninvasive intravesical drug delivery. Currently, liposomes, hydrogels, nanoparticles, and many other forms of carriers can be used to enhance bladder wall permeability. This facilitates the entry of BTX-A into the bladder wall, allowing it to exert its effects. In this review, the feasibility and efficacy of liposomes, thermosensitive hydrogels, and hyaluronic acid-phosphatidylethanolamine for the treatment of OAB in women are discussed along with recent animal experiments on the use of nanotechnology-delivered BTX-A for the treatment of OAB in female rat models. Although the clinical efficacy of nanocarrier-encapsulated BTX-A for the treatment of OAB in women has not yet matched that of direct urethral muscle injection of BTX-A, improvements in certain symptoms indicate the potential of bladder instillation of nanocarrier-encapsulated BTX-A for future clinical applications. Consequently, further research on nanomaterials is warranted to advance the development of nanocarriers for the noninvasive delivery of BTX-A in the bladder.

膀胱内注射A型肉毒毒素(BTX-A)对治疗难治性膀胱过动症(OAB)有效。然而,与注射相关的副作用,如血尿、疼痛和感染,以及需要反复注射,会降低患者的依从性,使治疗不方便。因此,泌尿科医生正在积极寻求微创和更方便的膀胱内给药BTX-A方法。纳米技术的进步促进了无创膀胱内给药。目前,脂质体、水凝胶、纳米颗粒和许多其他形式的载体可用于增强膀胱壁的通透性。这有利于BTX-A进入膀胱壁,使其发挥作用。在这篇综述中,讨论了脂质体、热敏水凝胶和透明质酸-磷脂酰乙醇胺治疗女性OAB的可行性和有效性,以及最近在雌性大鼠模型中使用纳米技术递送的BTX-A治疗OAB的动物实验。虽然纳米载体包埋BTX-A治疗女性OAB的临床疗效尚不能与直接尿道肌肉注射BTX-A相比,但在某些症状上的改善表明,纳米载体包埋BTX-A膀胱灌注在未来的临床应用中具有潜力。因此,有必要进一步研究纳米材料,以促进BTX-A在膀胱中无创递送的纳米载体的发展。
{"title":"Advancements in the management of overactive bladder in women using nano-botulinum toxin type A: A narrative review.","authors":"Yongheng Zhou, Qinggang Liu, Huiling Cong, Limin Liao","doi":"10.1097/CU9.0000000000000272","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000272","url":null,"abstract":"<p><p>Intravesical injections of botulinum toxin type A (BTX-A) are effective for treating refractory overactive bladder (OAB) in women. However, the adverse effects linked to the injections, such as hematuria, pain, and infection, and need for repeated injections can lower patient compliance and make the treatment inconvenient. Hence, urologists are actively pursuing less invasive and more convenient methods for the intravesical delivery of BTX-A. Advances in nanotechnology have facilitated noninvasive intravesical drug delivery. Currently, liposomes, hydrogels, nanoparticles, and many other forms of carriers can be used to enhance bladder wall permeability. This facilitates the entry of BTX-A into the bladder wall, allowing it to exert its effects. In this review, the feasibility and efficacy of liposomes, thermosensitive hydrogels, and hyaluronic acid-phosphatidylethanolamine for the treatment of OAB in women are discussed along with recent animal experiments on the use of nanotechnology-delivered BTX-A for the treatment of OAB in female rat models. Although the clinical efficacy of nanocarrier-encapsulated BTX-A for the treatment of OAB in women has not yet matched that of direct urethral muscle injection of BTX-A, improvements in certain symptoms indicate the potential of bladder instillation of nanocarrier-encapsulated BTX-A for future clinical applications. Consequently, further research on nanomaterials is warranted to advance the development of nanocarriers for the noninvasive delivery of BTX-A in the bladder.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 2","pages":"77-83"},"PeriodicalIF":0.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacteriophage therapy in women with chronic recurrent cystitis caused by multidrug-resistant bacteria: A prospective, observational, comparative study. 噬菌体治疗由多重耐药细菌引起的女性慢性复发性膀胱炎:一项前瞻性、观察性、比较研究。
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-27 DOI: 10.1097/CU9.0000000000000268
Denis Krakhotkin, Nikolai Iglovikov, Gideon Blecher, Vladimir Chernylovskyi, Francesco Greco, Svetlana A Gayvoronskaya, Amr El Meliegy

Objectives: The aim of this study was to evaluate the effects of the combination of bacteriophage therapy with antibiotics and bacteriophage treatment alone on relieving clinical symptoms of chronic recurrent cystitis caused by multidrug-resistant bacteria.

Materials and methods: This clinical trial compared the treatment methods of 217 female patients with chronic recurrent cystitis caused by multidrug-resistant bacteria, who were investigated from June 2020 to May 2023. Patients were allocated into 4 groups: group I: received bacteriophage (Sextaphage) therapy alone; group II: received a combination of bacteriophages (Sextaphage) and furazidin; group III: received a combination of bacteriophage (Sextaphage) and furazidin with cefixime; and group IV: received furazidin and cefixime (without bacteriophage). The primary outcome included changes in the acute cystitis symptom scale and the pain visual analog scale, which were completed on days 7 and 14 following treatment. Secondary outcome measures included bladder diary records of urinary symptoms, median voided volumes, level of bacteriuria, and degree of leukocyturia.

Results: Initially, 217 female patients were presented during baseline visits. Those who did not meet the criteria inclusions were excluded, and 178 female patients were included in the final analysis. Statistically significant improvements from baseline in acute cystitis symptom scale scores for differential, typical symptoms, and quality of life domains were observed after 14 days of treatment in groups II, III, and IV. The pain level measured on the 14th day with the visual analog scale significantly decreased in groups II, III, and IV compared with group I. The patients of group I had a reduction of mean level bacteriuria of Escherichia coli from 106 to 102 CFU/mL at 14 days of therapy. Significant improvement of voided volume from baseline was observed in groups II, III, and IV. Episodes of urinary frequency, both daytime and night-time, reduced significantly from baseline in all 4 groups only at 14 days of treatment.

Conclusions: Bacteriophage cocktail alone or with antibiotics may improve clinical symptoms in women with chronic recurrent cystitis caused by multidrug-resistant bacterial pathogens. In addition to improving clinical symptoms, the therapy with a phage cocktail may restore antibiotic sensitivity and increase the efficacy of antimicrobial agents.

目的:本研究旨在评价噬菌体联合抗生素治疗与单独噬菌体治疗对缓解多重耐药菌所致慢性复发性膀胱炎临床症状的效果。材料与方法:本临床试验对2020年6月至2023年5月217例女性多药耐药菌所致慢性复发性膀胱炎患者的治疗方法进行比较。将患者分为4组:第一组:单独给予噬菌体(Sextaphage)治疗;II组:给予噬菌体(Sextaphage)和呋喃肼联合治疗;III组:采用噬菌体(Sextaphage)、呋喃氮啶联合头孢克肟治疗;IV组:给予呋喃嗪和头孢克肟(不含噬菌体)。主要结局包括急性膀胱炎症状评分和疼痛视觉模拟评分的变化,分别于治疗后第7天和第14天完成。次要结局指标包括膀胱症状日记记录、中位排尿量、细菌尿水平和白细胞尿程度。结果:最初,217名女性患者在基线就诊期间就诊。排除不符合入选标准的患者,最终纳入178例女性患者。从基线显著改善急性膀胱炎的症状量表分数微分,典型症状和生活质量领域14天的治疗后观察组II, III和IV。第14天的疼痛水平测量的视觉模拟量表显著降低组II, III, IV组与组I患者相比我有减少平均水平的大肠杆菌菌尿106 - 102 CFU /毫升在14天的治疗。II、III和IV组的排尿量较基线有显著改善。仅在治疗14天后,所有4组的白天和夜间尿频次均较基线显著减少。结论:鸡尾酒噬菌体单用或联用抗生素可改善多药耐药病原菌所致女性慢性复发性膀胱炎的临床症状。除了改善临床症状外,噬菌体鸡尾酒疗法还可以恢复抗生素敏感性,提高抗菌药物的疗效。
{"title":"Bacteriophage therapy in women with chronic recurrent cystitis caused by multidrug-resistant bacteria: A prospective, observational, comparative study.","authors":"Denis Krakhotkin, Nikolai Iglovikov, Gideon Blecher, Vladimir Chernylovskyi, Francesco Greco, Svetlana A Gayvoronskaya, Amr El Meliegy","doi":"10.1097/CU9.0000000000000268","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000268","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to evaluate the effects of the combination of bacteriophage therapy with antibiotics and bacteriophage treatment alone on relieving clinical symptoms of chronic recurrent cystitis caused by multidrug-resistant bacteria.</p><p><strong>Materials and methods: </strong>This clinical trial compared the treatment methods of 217 female patients with chronic recurrent cystitis caused by multidrug-resistant bacteria, who were investigated from June 2020 to May 2023. Patients were allocated into 4 groups: group I: received bacteriophage (Sextaphage) therapy alone; group II: received a combination of bacteriophages (Sextaphage) and furazidin; group III: received a combination of bacteriophage (Sextaphage) and furazidin with cefixime; and group IV: received furazidin and cefixime (without bacteriophage). The primary outcome included changes in the acute cystitis symptom scale and the pain visual analog scale, which were completed on days 7 and 14 following treatment. Secondary outcome measures included bladder diary records of urinary symptoms, median voided volumes, level of bacteriuria, and degree of leukocyturia.</p><p><strong>Results: </strong>Initially, 217 female patients were presented during baseline visits. Those who did not meet the criteria inclusions were excluded, and 178 female patients were included in the final analysis. Statistically significant improvements from baseline in acute cystitis symptom scale scores for differential, typical symptoms, and quality of life domains were observed after 14 days of treatment in groups II, III, and IV. The pain level measured on the 14th day with the visual analog scale significantly decreased in groups II, III, and IV compared with group I. The patients of group I had a reduction of mean level bacteriuria of <i>Escherichia coli</i> from 10<sup>6</sup> to 10<sup>2</sup> CFU/mL at 14 days of therapy. Significant improvement of voided volume from baseline was observed in groups II, III, and IV. Episodes of urinary frequency, both daytime and night-time, reduced significantly from baseline in all 4 groups only at 14 days of treatment.</p><p><strong>Conclusions: </strong>Bacteriophage cocktail alone or with antibiotics may improve clinical symptoms in women with chronic recurrent cystitis caused by multidrug-resistant bacterial pathogens. In addition to improving clinical symptoms, the therapy with a phage cocktail may restore antibiotic sensitivity and increase the efficacy of antimicrobial agents.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 2","pages":"125-132"},"PeriodicalIF":0.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042198/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144044731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between cystitis glandularis and bladder neck leiomyoma: A case report and literature review. 腺性膀胱炎与膀胱颈部平滑肌瘤的关系:1例报告及文献复习。
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-21 DOI: 10.1097/CU9.0000000000000267
Caixia Zhang, Longlong Fan, Kuiqing Li, Li Huang, Lingjiao Chen, Yousheng Yao

This article reported the diagnosis and treatment of cystitis glandularis (CG) co-occurring with bladder neck leiomyomas. We retrospectively analyzed the clinical data of a single case of CG with bladder neck leiomyoma. A 31-year-old Chinese woman was given a diagnosis of CG and bladder neck leiomyoma. The mass and surrounding bladder mucosal lesions were entirely excised via transurethral resection, leaving a clean margin of healthy tissue. Histopathological analyses confirmed the diagnosis of CG and bladder neck leiomyoma. The patient remained asymptomatic throughout the follow-up period, with no indication of recurrence. Cystitis glandularis co-occurring with bladder neck leiomyoma requires careful examination, and surgery remains the best treatment option for these diseases.

本文报告腺性膀胱炎(CG)合并膀胱颈部平滑肌瘤的诊断与治疗。我们回顾性分析1例CG合并膀胱颈部平滑肌瘤的临床资料。一位31岁的中国女性被诊断为CG和膀胱颈部平滑肌瘤。经尿道切除肿块和周围膀胱粘膜病变,留下干净的健康组织边缘。组织病理学分析证实了CG和膀胱颈部平滑肌瘤的诊断。患者在随访期间无症状,无复发迹象。腺性膀胱炎合并膀胱颈部平滑肌瘤需要仔细检查,手术仍然是治疗这些疾病的最佳选择。
{"title":"Association between cystitis glandularis and bladder neck leiomyoma: A case report and literature review.","authors":"Caixia Zhang, Longlong Fan, Kuiqing Li, Li Huang, Lingjiao Chen, Yousheng Yao","doi":"10.1097/CU9.0000000000000267","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000267","url":null,"abstract":"<p><p>This article reported the diagnosis and treatment of cystitis glandularis (CG) co-occurring with bladder neck leiomyomas. We retrospectively analyzed the clinical data of a single case of CG with bladder neck leiomyoma. A 31-year-old Chinese woman was given a diagnosis of CG and bladder neck leiomyoma. The mass and surrounding bladder mucosal lesions were entirely excised via transurethral resection, leaving a clean margin of healthy tissue. Histopathological analyses confirmed the diagnosis of CG and bladder neck leiomyoma. The patient remained asymptomatic throughout the follow-up period, with no indication of recurrence. Cystitis glandularis co-occurring with bladder neck leiomyoma requires careful examination, and surgery remains the best treatment option for these diseases.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 2","pages":"133-137"},"PeriodicalIF":0.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of simultaneous electroacupuncture stimulation on the tibial and ilioinguinal-iliohypogastric nerves in the treatment of refractory overactive bladder syndrome in women. 电针同时刺激胫骨和髂腹股沟-髂腹下神经治疗难治性膀胱过动综合征的疗效观察。
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-21 DOI: 10.1097/CU9.0000000000000266
Tingting Lv, Weilin Fang, Junwen Si, Xiang Ji, Ziwei Li, Xin Song, Jin Huang, Zhijun Weng, Jianwei Lv

Objectives: The aim of this study was to observe the clinical effectiveness of simultaneous electroacupuncture stimulation on the tibial nerve (TN) and ilioinguinal-iliohypogastric nerve (IIN/IHN) in the treatment of refractory overactive bladder (OAB) in women.

Materials and methods: A prospective study was conducted involving 94 female patients with a diagnosis of OAB in the Urology Department of our hospital from September 2022 to October 2023. The patients were randomly divided into a TN-IIN/IHN group and a control group, each comprising 47 cases. All patients in both groups had received anticholinergic muscarinic receptor antagonists (tolterodine/solifenacin), β3 receptor agonists, flupentixol/melitracen, and other basic treatment regimens with poor results. The TN-IIN/IHN group received simultaneous electroacupuncture on the TN and IIN/IHN, whereas the control group received pelvic floor muscle biofeedback electrical stimulation. Both groups underwent treatment 3 times a week for a total of 4 weeks. Bladder symptoms (24-hour voiding diary), OAB Symptom Score, OAB-Quality of Life Questionnaire, and anxiety and depression scores were compared and analyzed before treatment, after treatment, and at a 3-month follow-up. Clinical efficacy was also assessed.

Results: Both groups showed significant improvement in voiding frequency, nocturia, urgency, OAB Symptom Score, and average voiding volume after treatment and at follow-up (p < 0.01). The TN-IIN/IHN group showed significantly superior results compared with the control group (p < 0.01). Quality of life scores and anxiety and depression scores significantly decreased (p < 0.01), with the TN-IIN/IHN group scores significantly lower than those of the control group (p < 0.01). The treatment success rate in the TN-IIN/IHN group was 84.78%, whereas that in the control group was 28.89%, showing a statistically significant difference (p < 0.01). No significant adverse reactions occurred in either group during the treatment period.

Conclusions: Simultaneous electroacupuncture on the TN and IIN/IHN is effective in treating refractory OAB in women and has good long-term efficacy. This therapy is safe, convenient, and free of significant adverse reactions, providing a new approach for the clinical treatment of refractory OAB in these patients. It significantly improves bladder symptoms and alleviates anxiety and depression, thereby markedly enhancing the patients' quality of life.

目的:观察电针同时刺激胫神经(TN)和髂腹股沟-髂腹下神经(IIN/IHN)治疗难治性膀胱过动症(OAB)的临床疗效。材料与方法:对2022年9月至2023年10月在我院泌尿外科诊断为OAB的女性患者94例进行前瞻性研究。将患者随机分为TN-IIN/IHN组和对照组,每组47例。两组患者均接受了抗胆碱能毒蕈碱受体拮抗剂(托特罗定/索利那新)、β3受体激动剂、氟哌替索/美利曲辛等基础治疗方案,但疗效不佳。TN-IIN/IHN组同时对TN和IIN/IHN进行电针治疗,对照组对盆底肌肉进行生物反馈电刺激。两组均每周治疗3次,共治疗4周。比较分析治疗前、治疗后和随访3个月时膀胱症状(24小时排尿日记)、OAB症状评分、OAB生活质量问卷、焦虑和抑郁评分。同时评估临床疗效。结果:两组治疗后及随访时排尿次数、夜尿、尿急、OAB症状评分、平均排尿量均有显著改善(p < 0.01)。与对照组相比,n - iin /IHN组疗效显著优于对照组(p < 0.01)。生活质量评分、焦虑抑郁评分均显著降低(p < 0.01),其中n - iin /IHN组显著低于对照组(p < 0.01)。n - iin /IHN组治疗成功率为84.78%,对照组为28.89%,差异有统计学意义(p < 0.01)。两组患者在治疗期间均未发生明显不良反应。结论:同时电针TN和IIN/IHN治疗难治性OAB女性有效,且远期疗效良好。该方法安全、方便、无明显不良反应,为临床治疗难治性OAB患者提供了新的途径。可明显改善膀胱症状,减轻焦虑和抑郁,从而显著提高患者的生活质量。
{"title":"Effectiveness of simultaneous electroacupuncture stimulation on the tibial and ilioinguinal-iliohypogastric nerves in the treatment of refractory overactive bladder syndrome in women.","authors":"Tingting Lv, Weilin Fang, Junwen Si, Xiang Ji, Ziwei Li, Xin Song, Jin Huang, Zhijun Weng, Jianwei Lv","doi":"10.1097/CU9.0000000000000266","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000266","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to observe the clinical effectiveness of simultaneous electroacupuncture stimulation on the tibial nerve (TN) and ilioinguinal-iliohypogastric nerve (IIN/IHN) in the treatment of refractory overactive bladder (OAB) in women.</p><p><strong>Materials and methods: </strong>A prospective study was conducted involving 94 female patients with a diagnosis of OAB in the Urology Department of our hospital from September 2022 to October 2023. The patients were randomly divided into a TN-IIN/IHN group and a control group, each comprising 47 cases. All patients in both groups had received anticholinergic muscarinic receptor antagonists (tolterodine/solifenacin), β3 receptor agonists, flupentixol/melitracen, and other basic treatment regimens with poor results. The TN-IIN/IHN group received simultaneous electroacupuncture on the TN and IIN/IHN, whereas the control group received pelvic floor muscle biofeedback electrical stimulation. Both groups underwent treatment 3 times a week for a total of 4 weeks. Bladder symptoms (24-hour voiding diary), OAB Symptom Score, OAB-Quality of Life Questionnaire, and anxiety and depression scores were compared and analyzed before treatment, after treatment, and at a 3-month follow-up. Clinical efficacy was also assessed.</p><p><strong>Results: </strong>Both groups showed significant improvement in voiding frequency, nocturia, urgency, OAB Symptom Score, and average voiding volume after treatment and at follow-up (<i>p</i> < 0.01). The TN-IIN/IHN group showed significantly superior results compared with the control group (<i>p</i> < 0.01). Quality of life scores and anxiety and depression scores significantly decreased (<i>p</i> < 0.01), with the TN-IIN/IHN group scores significantly lower than those of the control group (<i>p</i> < 0.01). The treatment success rate in the TN-IIN/IHN group was 84.78%, whereas that in the control group was 28.89%, showing a statistically significant difference (<i>p</i> < 0.01). No significant adverse reactions occurred in either group during the treatment period.</p><p><strong>Conclusions: </strong>Simultaneous electroacupuncture on the TN and IIN/IHN is effective in treating refractory OAB in women and has good long-term efficacy. This therapy is safe, convenient, and free of significant adverse reactions, providing a new approach for the clinical treatment of refractory OAB in these patients. It significantly improves bladder symptoms and alleviates anxiety and depression, thereby markedly enhancing the patients' quality of life.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 2","pages":"110-116"},"PeriodicalIF":0.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144031684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transurethral guidewire loop for manipulation and extraction of stent: A novel, innovative, video-endoscopic technique in ureteral stent removal. 经尿道导丝环用于支架操作和取出:一种新颖、创新的视频内窥镜技术用于输尿管支架取出
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-18 DOI: 10.1097/CU9.0000000000000170
Ahmed Adam, Marlon Perera

Background: Ureteral stent removal is one of the most common procedures performed in urology. Herein, we describe a novel technique for stent removal using transurethral guidewire loop for manipulation and extraction of stents method. We aimed to evaluate the role, feasibility, cost, operative time, and complications of the method. A review of the literature outlining the innovations in ureteral stent removal was also performed.

Materials and methods: Cystoscopic stent removal was performed using transurethral guidewire loop for manipulation and extraction of stents in all sequential cases. Variables including sex, age, stent type, duration, reason for stent insertion, type of anesthesia (general/local), cystoscopic stent removal time, and documentation of postprocedural complications were tabulated. In addition, using the search term "novel innovation in ureteral stent removal," various databases (PubMed, EMBASE, Cochrane Library, SCOPUS, and Web of Science) were searched.

Results: Transurethral guidewire loop for manipulation and extraction of stents was successfully performed in all patients assessed on the first attempt. The patients comprised both sexes. The procedure was well tolerated under local anesthesia (4 of 5 cases), whereas general anesthesia was used in 1 case as the patient was booked for subsequent ureteroscopy under the same anesthetic. The procedure time was <27 seconds in all the cases assessed. No significant complications were noted. Fifteen studies involving novel innovations were included in the critical appraisal.

Conclusions: Transurethral guidewire loop for manipulation and extraction of stents is a simple, cost-effective, and innovative alternative for removing ureteral stents. It may be easily applied instead of a conventional ureteral stent grasper. Published innovative trends in ureteral stent removal have evolved over time, including advancements in stent design, retrieval devices, and the use of fluoroscope-free and cystoscope-free techniques.

背景:输尿管支架移除术是泌尿外科最常见的手术之一。在此,我们描述了一种新的支架移除技术,采用经尿道导丝环操作和取出支架的方法。我们的目的是评估该方法的作用、可行性、成本、手术时间和并发症。回顾文献概述输尿管支架移除的创新也进行了。材料和方法:所有连续病例均采用经尿道导丝环操作和取出膀胱镜下支架。变量包括性别、年龄、支架类型、持续时间、支架置入原因、麻醉类型(全身/局部)、膀胱镜下支架取出时间和术后并发症记录。此外,使用搜索词“输尿管支架移除的新创新”,检索了各种数据库(PubMed, EMBASE, Cochrane Library, SCOPUS和Web of Science)。结果:经尿道导丝环支架的操作和取出在第一次尝试评估的所有患者都成功。病人包括男女。5例患者中有4例在局麻下耐受良好,而1例患者在相同的麻醉下预定后续输尿管镜检查,因此使用了全麻。结论:经尿道导丝环支架操作和取出是一种简单、经济、创新的输尿管支架取出方法。它可以很容易地代替传统的输尿管支架钳。已发表的输尿管支架移除的创新趋势随着时间的推移而发展,包括支架设计,取出装置以及无透视和无膀胱镜技术的使用的进步。
{"title":"Transurethral guidewire loop for manipulation and extraction of stent: A novel, innovative, video-endoscopic technique in ureteral stent removal.","authors":"Ahmed Adam, Marlon Perera","doi":"10.1097/CU9.0000000000000170","DOIUrl":"10.1097/CU9.0000000000000170","url":null,"abstract":"<p><strong>Background: </strong>Ureteral stent removal is one of the most common procedures performed in urology. Herein, we describe a novel technique for stent removal using transurethral guidewire loop for manipulation and extraction of stents method. We aimed to evaluate the role, feasibility, cost, operative time, and complications of the method. A review of the literature outlining the innovations in ureteral stent removal was also performed.</p><p><strong>Materials and methods: </strong>Cystoscopic stent removal was performed using transurethral guidewire loop for manipulation and extraction of stents in all sequential cases. Variables including sex, age, stent type, duration, reason for stent insertion, type of anesthesia (general/local), cystoscopic stent removal time, and documentation of postprocedural complications were tabulated. In addition, using the search term \"novel innovation in ureteral stent removal,\" various databases (PubMed, EMBASE, Cochrane Library, SCOPUS, and Web of Science) were searched.</p><p><strong>Results: </strong>Transurethral guidewire loop for manipulation and extraction of stents was successfully performed in all patients assessed on the first attempt. The patients comprised both sexes. The procedure was well tolerated under local anesthesia (4 of 5 cases), whereas general anesthesia was used in 1 case as the patient was booked for subsequent ureteroscopy under the same anesthetic. The procedure time was <27 seconds in all the cases assessed. No significant complications were noted. Fifteen studies involving novel innovations were included in the critical appraisal.</p><p><strong>Conclusions: </strong>Transurethral guidewire loop for manipulation and extraction of stents is a simple, cost-effective, and innovative alternative for removing ureteral stents. It may be easily applied instead of a conventional ureteral stent grasper. Published innovative trends in ureteral stent removal have evolved over time, including advancements in stent design, retrieval devices, and the use of fluoroscope-free and cystoscope-free techniques.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":" ","pages":"117-124"},"PeriodicalIF":0.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042180/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49516055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive review of conservative therapies for female stress urinary incontinence: Advancements, efficacy, and future directions. 女性压力性尿失禁的保守治疗综述:进展、疗效和未来方向。
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-21 DOI: 10.1097/CU9.0000000000000270
Can Luo, Xiaoyu Niu

Pelvic floor dysfunction poses a significant challenge to women worldwide. Female urinary incontinence is one of the most prevalent types of pelvic floor dysfunctions, affecting at least 50% of females, particularly those who are pregnant or menopausal. Among the various urinary incontinence subtypes, stress urinary incontinence takes the lead, characterized by involuntary urine leakage during activities that increase intra-abdominal pressure, such as sneezing, coughing, laughing, or exercising. This comprehensive review explores the latest advancements and critical insights into conservative treatments for stress urinary incontinence. Stress urinary incontinence symptoms result in profound physical and psychological consequences for individuals and impose a substantial medical and economic burden on society; however, only 5%-10% seek professional help. This narrative review meticulously examines a spectrum of interventions, ranging from lifestyle modifications to emerging modalities, such as laser treatment and electroacupuncture.

骨盆底功能障碍是全球女性面临的重大挑战。女性尿失禁是骨盆底功能障碍最常见的类型之一,影响至少50%的女性,特别是那些怀孕或更年期的女性。在各种尿失禁亚型中,以应激性尿失禁为主,其特征是在打喷嚏、咳嗽、大笑或运动等活动中增加腹内压力时不自主的尿漏。这篇综合综述探讨了压力性尿失禁保守治疗的最新进展和关键见解。压力性尿失禁症状对个人造成严重的生理和心理后果,并给社会造成沉重的医疗和经济负担;然而,只有5%-10%的人会寻求专业帮助。这篇叙述性综述细致地考察了一系列干预措施,从生活方式的改变到新兴的模式,如激光治疗和电针。
{"title":"A comprehensive review of conservative therapies for female stress urinary incontinence: Advancements, efficacy, and future directions.","authors":"Can Luo, Xiaoyu Niu","doi":"10.1097/CU9.0000000000000270","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000270","url":null,"abstract":"<p><p>Pelvic floor dysfunction poses a significant challenge to women worldwide. Female urinary incontinence is one of the most prevalent types of pelvic floor dysfunctions, affecting at least 50% of females, particularly those who are pregnant or menopausal. Among the various urinary incontinence subtypes, stress urinary incontinence takes the lead, characterized by involuntary urine leakage during activities that increase intra-abdominal pressure, such as sneezing, coughing, laughing, or exercising. This comprehensive review explores the latest advancements and critical insights into conservative treatments for stress urinary incontinence. Stress urinary incontinence symptoms result in profound physical and psychological consequences for individuals and impose a substantial medical and economic burden on society; however, only 5%-10% seek professional help. This narrative review meticulously examines a spectrum of interventions, ranging from lifestyle modifications to emerging modalities, such as laser treatment and electroacupuncture.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 2","pages":"84-89"},"PeriodicalIF":0.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent uncomplicated lower urinary tract infections in women. 女性复发性无并发症下尿路感染。
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-23 DOI: 10.1097/CU9.0000000000000273
Jiaxin Liu, Kaiyun Xu, Jiajie Hu, Lei Wang, Zhiyong Liu

Recurrent uncomplicated lower urinary tract infections (RULUTIs) are common among women without anatomical or physiological abnormalities and affect women of all age groups, races, and ethnicities. Herein, we summarized the sources of epidemiology, etiology, diagnosis, treatment, prophylaxis, and follow-up evaluations in cases of RULUTIs. Patients' medical histories, symptoms, and signs were recorded. The review showed that urinalysis, culture, and sensitivity should be tested before empiric treatment. A first-line therapeutic strategy should be applied based on the results of the urine culture and sensitivity tests. Therefore, estrogen should be used as an ancillary therapy. After the successful treatment of acute infections, intermittent or continuous prophylaxis can be administered. Patients may benefit from follow-up evaluations to avoid recurrent infections. We expect that clinicians will pay more attention to RULUTIs.

复发性无并发症下尿路感染(RULUTIs)常见于无解剖或生理异常的女性,可影响所有年龄组、种族和民族的女性。在此,我们总结了ruutis病例的流行病学,病因学,诊断,治疗,预防和随访评估的来源。记录患者的病史、症状和体征。回顾表明,在经验性治疗前应进行尿液分析、培养和敏感性测试。应根据尿培养和敏感性试验的结果采取一线治疗策略。因此,雌激素应作为辅助治疗。在成功治疗急性感染后,可进行间歇或连续预防。患者可能受益于随访评估,以避免复发性感染。我们期望临床医生对ruuti给予更多的关注。
{"title":"Recurrent uncomplicated lower urinary tract infections in women.","authors":"Jiaxin Liu, Kaiyun Xu, Jiajie Hu, Lei Wang, Zhiyong Liu","doi":"10.1097/CU9.0000000000000273","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000273","url":null,"abstract":"<p><p>Recurrent uncomplicated lower urinary tract infections (RULUTIs) are common among women without anatomical or physiological abnormalities and affect women of all age groups, races, and ethnicities. Herein, we summarized the sources of epidemiology, etiology, diagnosis, treatment, prophylaxis, and follow-up evaluations in cases of RULUTIs. Patients' medical histories, symptoms, and signs were recorded. The review showed that urinalysis, culture, and sensitivity should be tested before empiric treatment. A first-line therapeutic strategy should be applied based on the results of the urine culture and sensitivity tests. Therefore, estrogen should be used as an ancillary therapy. After the successful treatment of acute infections, intermittent or continuous prophylaxis can be administered. Patients may benefit from follow-up evaluations to avoid recurrent infections. We expect that clinicians will pay more attention to RULUTIs.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 2","pages":"90-94"},"PeriodicalIF":0.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042170/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer: Erratum. 勘误:异茚内酯抑制膀胱癌恶性行为机制的初步研究:勘误。
IF 1.3 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-07 DOI: 10.1097/CU9.0000000000000277
Qun Wang, Wenkai Xu, Lu Ying, Hongjin Shi, Yuxin Sun, Wei Feng, Haole Xu, Jun Xie, Hairong Wei, Zhao Yang, Haifeng Wang

[This corrects the article DOI: 10.1097/CU9.0000000000000259.].

[这更正了文章DOI: 10.1097/CU9.0000000000000259.]。
{"title":"Erratum: Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer: Erratum.","authors":"Qun Wang, Wenkai Xu, Lu Ying, Hongjin Shi, Yuxin Sun, Wei Feng, Haole Xu, Jun Xie, Hairong Wei, Zhao Yang, Haifeng Wang","doi":"10.1097/CU9.0000000000000277","DOIUrl":"10.1097/CU9.0000000000000277","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1097/CU9.0000000000000259.].</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 2","pages":"144"},"PeriodicalIF":1.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical-radiomics combination model for predicting the short-term efficacy of bipolar transurethral enucleation of the prostate in patients with benign prostatic hyperplasia. 临床-放射组学联合模型预测经尿道双极前列腺切除术对良性前列腺增生患者的短期疗效。
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-03 DOI: 10.1097/CU9.0000000000000256
Tianyou Zhang, Zijun Mo, Jiayu Huang, Jun Wang, Yiran Tao, Lei Ye, Wenwen Zhong, Bing Yao, Hu Qu, Bo Ma, Dejuan Wang, Jiahui Mo, Chunwei Ye, Junying Zhu, Jianguang Qiu

Background: Bipolar transurethral enucleation of the prostate (B-TUEP) is a well-established surgical treatment for benign prostatic hyperplasia (BPH); however, its efficacy may vary depending on patient characteristics. Magnetic resonance imaging (MRI) with radiomics analysis can offer comprehensive and quantitative information about prostate characteristics that may relate to surgical outcomes. This study aimed to explore the value of MRI and radiomics analysis in predicting the short-term efficacy of B-TUEP for BPH.

Materials and methods: A total of 137 patients with BPH who underwent B-TUEP at 2 institutions were included. Radiological features were measured in the MRIs, and the radiomics score was developed from 1702 radiomics features extracted from the prostate and transitional zone regions of interest. Three prediction models were developed and validated based on clinical-radiological features, radiomic features, and their combinations. The models were evaluated using the area under the receiver operating characteristic curve, calibration curve, and decision curve analysis.

Results: The combination model exhibited the highest area under curve in both the training set (0.838) and the external validation set (0.802), indicating superior predictive performance and robustness. Furthermore, the combination model demonstrated good calibration (p > 0.05) and optimal clinical utility. The combination model indicated that a higher maximum urine flow rate, lower transitional zone index, and higher radiomics score were associated with an increased risk of poor efficacy.

Conclusions: Magnetic resonance imaging with radiomic analysis can offer valuable insights for predicting the short-term efficacy of B-TUEP in patients with BPH. A combination model based on clinical and radiomics features can assist urologists in making more precise clinical decisions.

背景:双极经尿道前列腺摘除(B-TUEP)是一种公认的治疗良性前列腺增生(BPH)的手术方法;然而,其疗效可能因患者特点而异。磁共振成像(MRI)与放射组学分析可以提供有关前列腺特征的全面和定量信息,这些特征可能与手术结果有关。本研究旨在探讨MRI和放射组学分析在预测B-TUEP治疗BPH的短期疗效中的价值。材料和方法:在2所医院接受B-TUEP治疗的BPH患者共137例。在mri中测量放射学特征,放射组学评分是根据从前列腺和感兴趣的过渡区提取的1702个放射组学特征开发的。基于临床-放射学特征、放射学特征及其组合,建立并验证了三种预测模型。采用受试者工作特性曲线下面积、校准曲线和决策曲线分析对模型进行评价。结果:组合模型在训练集(0.838)和外部验证集(0.802)的曲线下面积均最高,具有较好的预测性能和稳健性。此外,联合模型具有良好的校正效果(p < 0.05)和最佳的临床应用价值。联合模型显示,较高的最大尿流率、较低的过渡区指数和较高的放射组学评分与疗效差的风险增加相关。结论:磁共振成像与放射学分析可以为预测BPH患者B-TUEP的短期疗效提供有价值的见解。基于临床和放射组学特征的组合模型可以帮助泌尿科医生做出更精确的临床决策。
{"title":"Clinical-radiomics combination model for predicting the short-term efficacy of bipolar transurethral enucleation of the prostate in patients with benign prostatic hyperplasia.","authors":"Tianyou Zhang, Zijun Mo, Jiayu Huang, Jun Wang, Yiran Tao, Lei Ye, Wenwen Zhong, Bing Yao, Hu Qu, Bo Ma, Dejuan Wang, Jiahui Mo, Chunwei Ye, Junying Zhu, Jianguang Qiu","doi":"10.1097/CU9.0000000000000256","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000256","url":null,"abstract":"<p><strong>Background: </strong>Bipolar transurethral enucleation of the prostate (B-TUEP) is a well-established surgical treatment for benign prostatic hyperplasia (BPH); however, its efficacy may vary depending on patient characteristics. Magnetic resonance imaging (MRI) with radiomics analysis can offer comprehensive and quantitative information about prostate characteristics that may relate to surgical outcomes. This study aimed to explore the value of MRI and radiomics analysis in predicting the short-term efficacy of B-TUEP for BPH.</p><p><strong>Materials and methods: </strong>A total of 137 patients with BPH who underwent B-TUEP at 2 institutions were included. Radiological features were measured in the MRIs, and the radiomics score was developed from 1702 radiomics features extracted from the prostate and transitional zone regions of interest. Three prediction models were developed and validated based on clinical-radiological features, radiomic features, and their combinations. The models were evaluated using the area under the receiver operating characteristic curve, calibration curve, and decision curve analysis.</p><p><strong>Results: </strong>The combination model exhibited the highest area under curve in both the training set (0.838) and the external validation set (0.802), indicating superior predictive performance and robustness. Furthermore, the combination model demonstrated good calibration (<i>p</i> > 0.05) and optimal clinical utility. The combination model indicated that a higher maximum urine flow rate, lower transitional zone index, and higher radiomics score were associated with an increased risk of poor efficacy.</p><p><strong>Conclusions: </strong>Magnetic resonance imaging with radiomic analysis can offer valuable insights for predicting the short-term efficacy of B-TUEP in patients with BPH. A combination model based on clinical and radiomics features can assist urologists in making more precise clinical decisions.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 1","pages":"30-38"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive visual report of urodynamic study in rats with spinal cord injury. 脊髓损伤大鼠尿动力学研究的综合视觉报告
IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-01-01 Epub Date: 2022-09-16 DOI: 10.1097/CU9.0000000000000150
Hanieh Salehi-Pourmehr, Javad Mahmoudi, Arman Saeedi Vahdat, Sakineh Hajebrahimi, Nasrin Abolhasanpour

Objectives: Spinal cord injury (SCI) is one of the most debilitating and expensive traumatic conditions. Chronic complications after SCI have a particularly negative impact on patients' functional independence and quality of life. Urodynamic study (UDS) provides a quantitative assessment of lower urinary tract function in these patients. In many fields, animal models are considered a precursor to clinical trials, so research using laboratory animals play a major role in knowledge acquisition.

Materials and methods: Twelve female Wistar rats (13 weeks old, 220-270 g) were divided randomly into 2 groups: sham or SCI. The sham-operated group underwent a laminectomy at T9-T10 without any spinal cord damage, while the SCI group underwent a complete transection at the T9-T10 vertebral level. We performed cystometry in all animals at the end of the fourth week. In this article, we visualize all procedures for catheter implementation and UDS in animals for the first time at Tabriz University of Medical Sciences, Iran, using a locally developed animal UDS device.

Results: The UDS results showed that the bladders in the SCI group were overactive and that peak and baseline pressures increased significantly in rats with SCI when compared with the sham group (p < 0.05 for all). Conversely, significant reductions in bladder compliance and intercontraction interval were observed in the SCI group (p < 0.05 for both).

Conclusions: This comprehensive visual report will be very useful to all researchers in the field of urology. Furthermore, the measurable variables of the UDS device have been described in this study.

目的:脊髓损伤(SCI)是最令人虚弱和昂贵的创伤性疾病之一。脊髓损伤后的慢性并发症对患者的功能独立性和生活质量的影响尤为严重。尿动力学研究(UDS)为这些患者的下尿路功能提供了定量评估。在许多领域,动物模型被认为是临床试验的先驱,因此使用实验动物的研究在知识获取中起着重要作用。材料与方法:雌性Wistar大鼠12只,13周龄,220 ~ 270 g,随机分为sham组和SCI组。假手术组在T9-T10处行椎板切除术,无脊髓损伤,而SCI组在T9-T10椎体水平行完全横断。我们在第四周结束时对所有动物进行了膀胱测量。在这篇文章中,我们首次在伊朗大不里士医科大学使用当地开发的动物UDS设备,可视化了动物导管置入和UDS的所有过程。结果:UDS结果显示,与假手术组相比,SCI组大鼠膀胱过度活跃,峰值和基线压力均显著升高(p < 0.05)。相反,脊髓损伤组膀胱顺应性和收缩间期明显缩短(p < 0.05)。结论:这份综合性的视觉报告对泌尿外科研究人员有一定的参考价值。此外,本研究还描述了UDS设备的可测量变量。
{"title":"A comprehensive visual report of urodynamic study in rats with spinal cord injury.","authors":"Hanieh Salehi-Pourmehr, Javad Mahmoudi, Arman Saeedi Vahdat, Sakineh Hajebrahimi, Nasrin Abolhasanpour","doi":"10.1097/CU9.0000000000000150","DOIUrl":"10.1097/CU9.0000000000000150","url":null,"abstract":"<p><strong>Objectives: </strong>Spinal cord injury (SCI) is one of the most debilitating and expensive traumatic conditions. Chronic complications after SCI have a particularly negative impact on patients' functional independence and quality of life. Urodynamic study (UDS) provides a quantitative assessment of lower urinary tract function in these patients. In many fields, animal models are considered a precursor to clinical trials, so research using laboratory animals play a major role in knowledge acquisition.</p><p><strong>Materials and methods: </strong>Twelve female Wistar rats (13 weeks old, 220-270 g) were divided randomly into 2 groups: sham or SCI. The sham-operated group underwent a laminectomy at T9-T10 without any spinal cord damage, while the SCI group underwent a complete transection at the T9-T10 vertebral level. We performed cystometry in all animals at the end of the fourth week. In this article, we visualize all procedures for catheter implementation and UDS in animals for the first time at Tabriz University of Medical Sciences, Iran, using a locally developed animal UDS device.</p><p><strong>Results: </strong>The UDS results showed that the bladders in the SCI group were overactive and that peak and baseline pressures increased significantly in rats with SCI when compared with the sham group (<i>p</i> < 0.05 for all). Conversely, significant reductions in bladder compliance and intercontraction interval were observed in the SCI group (<i>p</i> < 0.05 for both).</p><p><strong>Conclusions: </strong>This comprehensive visual report will be very useful to all researchers in the field of urology. Furthermore, the measurable variables of the UDS device have been described in this study.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":" ","pages":"59-63"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43675254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1